1. Targeting the Nogo Receptor to Treat Central Nervous System Injuries
2. Systemic Deletion of the Myelin-Associated Outgrowth Inhibitor Nogo-A Improves Regenerative and Plastic Responses after Spinal Cord Injury
3. Nogo and axon regeneration
4. Targeting the Nogo-A Signalling Pathway to Promote Recovery Following Acute CNS Injury
5. V. Meininger , P. F.Pradat, A.Crose, S.Al-Sarraj, B. R.Brooks, J. B.Caress, M.Cudkowicz, S. J.Kolb, D.Lange, P. N.Leigh, T.Meyer, S.Milleri, K. E.Morrison, R. W.Orrel, G.Peters, J. D.Rothstein, J.Shefner, A.Lavrov, N.Williams, P.Overend, J.Price, S.Bates, J.Bullman, D.Krull, A.Berges, B.Abila, G.Meno-Tetang and J.Wurthner, Safety, pharmacokinetic, and functional effects of the Nogo-A monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-man study, submitted for publication